Ensign Peak Advisors, Inc
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1454984
SALT LAKE CITY, UT
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$556,063
+$24,041 QoQ
Shares Held
9,718
+3.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#328
of 561 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. BMRN ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in BMRN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $556,063 | 9,718 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $532,022 | 9,418 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $559,711 | 9,418 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,552,658 | 28,668 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,244,219 | 59,018 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,408,652 | 62,366 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,066,583 | 61,868 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,770,090 | 67,863 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,918,539 | 71,888 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,303,153 | 72,168 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,232,045 | 157,976 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,607,070 | 119,881 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,570,712 | 121,951 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,278,170 | 105,699 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,055,032 | 242,101 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,613,118 | 219,572 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,485,315 | 90,326 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,499,569 | 45,390 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,699,336 | 53,190 | Shares | Sole | 2022-02-11 | |
| 2020-09-30 | $1,252,200 | 16,459 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||